BioSpace News Archive

Mylab Discovery Solutions, India’s leading biotechnology company, has joined forces with the United States-based Hemex Health, a medical diagnostic device company focused on creating life-changing global health products, to develop next-generation diagnostic solutions for the Point-of-Care (POC) testing of coronavirus and other diseases.

Twist Bioscience Corporation today announced that Jim Thorburn, CFO of Twist Bioscience, and Patrick Finn, chief commercial officer, will host a fireside chat at the UBS Genomics 2.0 and Medtech Innovations Summit on August 11 th at 2:00 p.m. P.T. in Laguna Beach, California.

Koya Medical, a healthcare company focused on developing breakthrough treatments for lymphedema and venous diseases, announced today that its wearable, active compression therapy system for lymphedema—Dayspring™— was issued new billing codes by the Center of Medicare & Medicaid Services (CMS) in accordance with the Healthcare Common Procedure Coding System (HCPCS).

Ocular Therapeutix, Inc. today announced that it will participate in two panels and will provide a pre-recorded presentation at the H.C. Wainwright Ophthalmology Virtual Conference being held on Tuesday, August 17th, 2021.

Goldfinch Bio today announced that it has dosed the first patient in an open-label extension study for patients with focal segmental glomerular sclerosis (FSGS) enrolled in its Phase 2 TRACTION-2 clinical trial of GFB-887

StatLab Medical Products (“StatLab”), a leading developer and manufacturer of diagnostic supplies and equipment for the anatomic pathology market, has acquired Pyramid Innovation (“Pyramid”).

EmpiraMed, Inc., a digital health technology leader in the field of Virtual Clinical Studies for Real World Evidence, today announced that Happify Health selected EmpiraMed to perform the interventional clinical trial for their Ensemble investigational prescription digital therapeutic (DTx) for the purpose of FDA regulatory approval consideration.

Longeveron Inc. today announced that the Company will release its second quarter 2021 financial results on Friday, August 13, 2021 before the open of US markets. Management will host a conference call on the same day at 8:00 AM.

Cognoptix, a groundbreaking diagnostic company for the early-stage detection of Alzheimer’s disease (AD), announces today that Marwan Noel Sabbagh, MD has joined Cognoptix’ Scientific Advisory Board.

Far infrared light is measured in microns and can be divided into far-infrared, mid-infrared, and near-infrared.